CN Stock MarketDetailed Quotes

Xiamen Amoytop Biotech (688278)

Watchlist
  • 58.25
  • -1.10-1.85%
Market Closed Apr 30 15:00 CST
23.78BMarket Cap23.46P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xiamen Amoytop Biotech (688278) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
18.48%797.79M
31.18%3.7B
26.85%2.48B
26.96%1.51B
23.48%673.35M
34.13%2.82B
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
Operating revenue
18.48%797.79M
31.18%3.7B
26.85%2.48B
26.96%1.51B
23.48%673.35M
34.13%2.82B
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
Total operating cost
32.10%608.61M
31.88%2.48B
32.49%1.72B
25.51%1.03B
21.34%460.73M
31.05%1.88B
30.42%1.3B
27.57%816.75M
24.66%379.69M
23.30%1.44B
Operating cost
83.04%84.14M
41.68%259.99M
42.02%184.53M
34.27%106.03M
21.71%45.96M
31.03%183.51M
38.79%129.93M
23.73%78.97M
0.09%37.77M
-17.24%140.05M
Operating tax surcharges
194.38%10.15M
45.36%19.96M
32.33%12.71M
24.80%7.64M
23.38%3.45M
22.23%13.73M
21.45%9.61M
26.78%6.12M
31.27%2.79M
43.30%11.24M
Operating expense
17.67%328.37M
30.37%1.45B
29.72%1.01B
19.85%598.91M
15.36%279.06M
31.16%1.11B
29.13%777.95M
20.99%499.73M
29.96%241.91M
20.71%848.8M
Administration expense
36.74%92.13M
30.75%363.91M
25.08%237.84M
17.48%140.33M
23.86%67.37M
32.35%278.34M
24.79%190.15M
43.78%119.45M
29.70%54.39M
51.98%210.31M
Financial expense
109.72%180.41K
3.95%-2.09M
-27.99%-2.38M
-84.14%-2.62M
-147.29%-1.86M
54.78%-2.18M
39.54%-1.86M
17.61%-1.42M
30.08%-750.94K
-15.10%-4.81M
-Interest expense (Financial expense)
483.66%686.79K
214.68%1.42M
113.90%764.38K
65.61%379.94K
3.12%117.67K
-10.57%452.68K
-3.77%357.36K
-8.10%229.42K
-2.77%114.11K
-18.46%506.17K
-Interest Income (Financial expense)
53.86%-904.21K
-37.46%-4.04M
-45.44%-3.39M
-61.84%-2.9M
-100.95%-1.96M
55.62%-2.94M
51.36%-2.33M
42.52%-1.79M
25.64%-975.13K
-45.04%-6.63M
Research and development
40.29%93.64M
31.66%388.03M
44.48%279.34M
53.46%174.8M
53.18%66.75M
28.15%294.71M
35.34%193.34M
47.53%113.91M
15.55%43.58M
53.48%229.98M
Credit Impairment Loss
-25.38%581.91K
98.33%-60.36K
117.53%95.99K
966.46%986.04K
512.20%779.81K
-678.02%-3.61M
11.81%-547.47K
88.74%-113.8K
135.01%127.38K
-132.95%-463.8K
Asset Impairment Loss
----
----
----
----
----
----
----
----
----
---12.76M
Other net revenue
Fair value change income
-90.38%3.89K
290.55%3.45M
-17.31%1.07M
-31.78%590.54K
--40.46K
-66.69%882.87K
689.64%1.29M
708.65%865.58K
----
566.55%2.65M
Invest income
22.45%1.66M
62.81%6.6M
14.70%2.62M
12.18%1.87M
-2.99%1.35M
14.27%4.05M
1.13%2.28M
-11.91%1.67M
-26.34%1.4M
0.74%3.55M
Asset deal income
6,149.79%626.71K
-1,198.43%-718.03K
-68.19%14.47K
-68.65%14.09K
-77.69%10.03K
639.43%65.37K
456.60%45.5K
941.82%44.95K
--44.95K
-90.80%8.84K
Other revenue
27.34%6.58M
-19.52%27.01M
34.79%19.26M
-16.12%8.15M
55.04%5.17M
46.04%33.56M
-6.00%14.29M
125.39%9.72M
21.96%3.33M
-40.87%22.98M
Operating profit
-9.70%198.63M
28.83%1.25B
16.11%781.39M
29.05%497.15M
29.00%219.96M
42.60%970.74M
40.00%672.95M
43.41%385.24M
43.30%170.52M
67.28%680.72M
Add:Non operating Income
-37.67%142.86K
69.61%1.16M
16.13%744.46K
12.26%598.96K
-54.32%229.2K
50.59%682.28K
129.28%641.07K
119.43%533.53K
188.13%501.72K
47.52%453.06K
Less:Non operating expense
79.79%19.74M
89.21%76.43M
83.70%51.13M
6.43%21.48M
-19.57%10.98M
-0.31%40.39M
-16.39%27.84M
-9.20%20.18M
-10.58%13.65M
-21.02%40.52M
Total profit
-14.42%179.04M
26.25%1.18B
13.20%731M
30.27%476.27M
32.95%209.22M
45.32%931.03M
44.25%645.75M
48.22%365.6M
51.46%157.37M
80.00%640.65M
Less:Income tax cost
-46.30%14.55M
39.37%144.14M
-29.18%64.87M
-21.02%48.38M
-5.16%27.09M
21.38%103.42M
16.30%91.6M
37.72%61.26M
44.77%28.56M
23.65%85.21M
Net profit
-9.68%164.49M
24.61%1.03B
20.21%666.12M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
Net profit from continuing operation
-9.68%164.49M
24.61%1.03B
20.21%666.12M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
Net profit of parent company owners
-9.68%164.49M
24.61%1.03B
20.21%666.12M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
Earning per share
Basic earning per share
-11.11%0.4
24.63%2.53
20.59%1.64
40.00%1.05
40.63%0.45
48.18%2.03
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
Diluted earning per share
-11.11%0.4
24.14%2.52
20.59%1.64
40.00%1.05
40.63%0.45
48.18%2.03
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
Other composite income
-81.74K
Other composite income of parent company owners
----
----
---81.74K
----
----
----
----
----
----
----
Total composite income
-9.68%164.49M
24.61%1.03B
20.19%666.04M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
Total composite income of parent company owners
-9.68%164.49M
24.61%1.03B
20.19%666.04M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
--
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 18.48%797.79M31.18%3.7B26.85%2.48B26.96%1.51B23.48%673.35M34.13%2.82B33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B
Operating revenue 18.48%797.79M31.18%3.7B26.85%2.48B26.96%1.51B23.48%673.35M34.13%2.82B33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B
Total operating cost 32.10%608.61M31.88%2.48B32.49%1.72B25.51%1.03B21.34%460.73M31.05%1.88B30.42%1.3B27.57%816.75M24.66%379.69M23.30%1.44B
Operating cost 83.04%84.14M41.68%259.99M42.02%184.53M34.27%106.03M21.71%45.96M31.03%183.51M38.79%129.93M23.73%78.97M0.09%37.77M-17.24%140.05M
Operating tax surcharges 194.38%10.15M45.36%19.96M32.33%12.71M24.80%7.64M23.38%3.45M22.23%13.73M21.45%9.61M26.78%6.12M31.27%2.79M43.30%11.24M
Operating expense 17.67%328.37M30.37%1.45B29.72%1.01B19.85%598.91M15.36%279.06M31.16%1.11B29.13%777.95M20.99%499.73M29.96%241.91M20.71%848.8M
Administration expense 36.74%92.13M30.75%363.91M25.08%237.84M17.48%140.33M23.86%67.37M32.35%278.34M24.79%190.15M43.78%119.45M29.70%54.39M51.98%210.31M
Financial expense 109.72%180.41K3.95%-2.09M-27.99%-2.38M-84.14%-2.62M-147.29%-1.86M54.78%-2.18M39.54%-1.86M17.61%-1.42M30.08%-750.94K-15.10%-4.81M
-Interest expense (Financial expense) 483.66%686.79K214.68%1.42M113.90%764.38K65.61%379.94K3.12%117.67K-10.57%452.68K-3.77%357.36K-8.10%229.42K-2.77%114.11K-18.46%506.17K
-Interest Income (Financial expense) 53.86%-904.21K-37.46%-4.04M-45.44%-3.39M-61.84%-2.9M-100.95%-1.96M55.62%-2.94M51.36%-2.33M42.52%-1.79M25.64%-975.13K-45.04%-6.63M
Research and development 40.29%93.64M31.66%388.03M44.48%279.34M53.46%174.8M53.18%66.75M28.15%294.71M35.34%193.34M47.53%113.91M15.55%43.58M53.48%229.98M
Credit Impairment Loss -25.38%581.91K98.33%-60.36K117.53%95.99K966.46%986.04K512.20%779.81K-678.02%-3.61M11.81%-547.47K88.74%-113.8K135.01%127.38K-132.95%-463.8K
Asset Impairment Loss ---------------------------------------12.76M
Other net revenue
Fair value change income -90.38%3.89K290.55%3.45M-17.31%1.07M-31.78%590.54K--40.46K-66.69%882.87K689.64%1.29M708.65%865.58K----566.55%2.65M
Invest income 22.45%1.66M62.81%6.6M14.70%2.62M12.18%1.87M-2.99%1.35M14.27%4.05M1.13%2.28M-11.91%1.67M-26.34%1.4M0.74%3.55M
Asset deal income 6,149.79%626.71K-1,198.43%-718.03K-68.19%14.47K-68.65%14.09K-77.69%10.03K639.43%65.37K456.60%45.5K941.82%44.95K--44.95K-90.80%8.84K
Other revenue 27.34%6.58M-19.52%27.01M34.79%19.26M-16.12%8.15M55.04%5.17M46.04%33.56M-6.00%14.29M125.39%9.72M21.96%3.33M-40.87%22.98M
Operating profit -9.70%198.63M28.83%1.25B16.11%781.39M29.05%497.15M29.00%219.96M42.60%970.74M40.00%672.95M43.41%385.24M43.30%170.52M67.28%680.72M
Add:Non operating Income -37.67%142.86K69.61%1.16M16.13%744.46K12.26%598.96K-54.32%229.2K50.59%682.28K129.28%641.07K119.43%533.53K188.13%501.72K47.52%453.06K
Less:Non operating expense 79.79%19.74M89.21%76.43M83.70%51.13M6.43%21.48M-19.57%10.98M-0.31%40.39M-16.39%27.84M-9.20%20.18M-10.58%13.65M-21.02%40.52M
Total profit -14.42%179.04M26.25%1.18B13.20%731M30.27%476.27M32.95%209.22M45.32%931.03M44.25%645.75M48.22%365.6M51.46%157.37M80.00%640.65M
Less:Income tax cost -46.30%14.55M39.37%144.14M-29.18%64.87M-21.02%48.38M-5.16%27.09M21.38%103.42M16.30%91.6M37.72%61.26M44.77%28.56M23.65%85.21M
Net profit -9.68%164.49M24.61%1.03B20.21%666.12M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M
Net profit from continuing operation -9.68%164.49M24.61%1.03B20.21%666.12M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M
Net profit of parent company owners -9.68%164.49M24.61%1.03B20.21%666.12M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M
Earning per share
Basic earning per share -11.11%0.424.63%2.5320.59%1.6440.00%1.0540.63%0.4548.18%2.0349.45%1.3650.00%0.7552.38%0.3292.96%1.37
Diluted earning per share -11.11%0.424.14%2.5220.59%1.6440.00%1.0540.63%0.4548.18%2.0349.45%1.3650.00%0.7552.38%0.3292.96%1.37
Other composite income -81.74K
Other composite income of parent company owners -----------81.74K----------------------------
Total composite income -9.68%164.49M24.61%1.03B20.19%666.04M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M
Total composite income of parent company owners -9.68%164.49M24.61%1.03B20.19%666.04M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------------Unqualified opinion
Auditor ------------------Rongcheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -